<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809802/" ref="ordinalpos=2200&amp;ncbi_uid=2731163&amp;link_uid=PMC2809802" image-link="/pmc/articles/PMC2809802/figure/F1/" class="imagepopup">Figure 1. Schematic representation of agonist-selective <span class="highlight" style="background-color:">signaling</span>.  From: Agonist-Selective <span class="highlight" style="background-color:">Signaling</span> of G Protein-Coupled Receptor: Mechanisms and Implications. </a></div><br /><div class="p4l_captionBody">Agonist I and II exhibit differential efficacies in pathway A and B. The “Full Agonist” and “Neutral Antagonist” were used to indicate the different “intrinsic efficacies” of these agonists on the two pathways. Also, they can be “Partial Agonist” or “Inverse Agonist”.</div></div>